Literature DB >> 31184738

Drugs for Postmenopausal Osteoporosis.

.   

Abstract

Entities:  

Year:  2019        PMID： 31184738     DOI： 10.1001/jama.2019.6077

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Personalising osteoporosis treatment for patients at high risk of fracture.

Authors:  Sundeep Khosla
Journal:  Lancet Diabetes Endocrinol       Date:  2019-08-22       Impact factor: 32.069

2.  PiRNA-63049 inhibits bone formation through Wnt/β-catenin signaling pathway.

Authors:  Gaoyang Chen; Shang Wang; Canling Long; Zhenmin Wang; Xin Chen; Wanze Tang; Xiaoqin He; Zhiteng Bao; Baoyu Tan; William W Lu; Zhizhong Li; Dazhi Yang; Guozhi Xiao; Songlin Peng
Journal:  Int J Biol Sci       Date:  2021-10-25       Impact factor: 6.580

Review 3.  Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors.

Authors:  Jason T Wan; Douglas M Sheeley; Martha J Somerman; Janice S Lee
Journal:  Bone Res       Date:  2020-03-11       Impact factor: 13.567
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.